Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms.
PHASE3CompletedINTERVENTIONAL
Enrollment
48
Participants
Timeline
Start Date
July 31, 2004
Study Completion Date
September 30, 2005
Conditions
Gastroesophageal RefluxHeartburn
Interventions
DRUG
rabeprazole
All Listed Sponsors
lead
Janssen-Ortho Inc., Canada
INDUSTRY
NCT00553449 - Open Label Study Evaluating Different Dosing Regimens of Rabeprazole in Gastro-esophageal Reflux Disease (GERD) Patients With Night-time Heartburn Symptoms. | Biotech Hunter | Biotech Hunter